- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07752017
Validity and Reliability of the 2-Minute Step Test in Patients With Lipedema
Construct Validity and Reliability of the 2-Minute Step Test in Patients With Lipedema: A Cross-Sectional Study
Lipedema is a chronic, progressive adipose tissue disorder that predominantly affects women and is characterized by symmetric, disproportionate subcutaneous fat accumulation in the lower extremities, pain, tenderness, and easy bruising. It is associated with reduced mobility and impaired functional capacity. Although the 2-Minute Step Test (2MST) is a practical, low-cost measure of functional capacity that requires no equipment or large space, its validity and reliability have not been investigated in patients with lipedema. The aim of this study is to evaluate the construct validity and test-retest reliability of the 2MST in women with lipedema.
Aperçu de l'étude
Statut
Les conditions
Description détaillée
This prospective, cross-sectional study will enroll 55 women diagnosed with lipedema (stage 2 and above) according to the Wold and Halk-Damstra criteria. Participants will undergo the 2-Minute Step Test (2MST), the 6-Minute Walk Test (6MWT), the Timed Up and Go Test (TUGT), the Visual Analog Scale (VAS) for pain, and the Lower Extremity Functional Scale (LEFS). Vital signs (blood pressure, oxygen saturation, heart rate) will be checked before testing. Tests will be administered in a fixed order (2MST, then 6MWT, then TUGT) with at least 30 minutes of rest between them, by the same examiner, at similar times of day. To assess test-retest reliability, the 2MST will be repeated after a 7-day interval by the same examiner. Reliability will be evaluated using the intraclass correlation coefficient (ICC) with 95% confidence intervals, standard error of measurement (SEM), and minimum detectable change (MDC95). Construct validity will be evaluated using Spearman correlation coefficients between the 2MST and the 6MWT, TUGT, LEFS, and VAS.
Type d'étude
Inscription (Estimé)
Contacts et emplacements
Coordonnées de l'étude
- Nom: Merve Aydın, MD
- Numéro de téléphone: 2124445434
- E-mail: merveay9702@gmail.com
Lieux d'étude
-
-
Bahcelievler
-
Istanbul, Bahcelievler, Turquie (Türkiye), 34100
- Recrutement
- İstanbul Physical Medicine and Rehabilitation Research and Training Hospital
-
Contact:
- Merve Aydin, MD
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
Patients with lipedema
La description
Inclusion Criteria:
- Clinically diagnosed with lipedema according to the Wold and Halk-Damstra criteria, stage 2 and above
- Aged 18-65 years, female
- No walking-limiting pathology
- Willing to participate
Exclusion Criteria:
- Uncontrolled hypertension
- Decompensated cardiac failure
- Systemic, degenerative, neurological, rheumatological, or orthopedic disease affecting lower-extremity function
- Lower-extremity surgery within the past 6 months
- Peripheral artery disease causing vascular claudication
- Severe psychiatric disorder (active psychosis, severe major depression) or cognitive impairment preventing compliance with test instructions
- Neuromuscular disease
- Pregnancy
- Advanced-stage lipo-lymphedema severely restricting ambulation
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Modèles d'observation: CASE_ONLY
- Perspectives temporelles: CROSS_SECTIONAL
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
2-Minute Step Test (2MST)
Délai: Baseline
|
Functional exercise capacity assessed by the number of times the participant raises the knee to the required height during 2 minutes. Higher scores indicate better functional exercise capacity. |
Baseline
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
6-Minute Walk Test (6MWT)
Délai: Baseline
|
Functional exercise capacity assessed by the total distance walked in 6 minutes (meters). Greater walking distance indicates better functional capacity and endurance. |
Baseline
|
|
Timed Up and Go Test (TUGT)
Délai: Baseline
|
Functional mobility assessed by the time required to stand up from a chair, walk 3 meters, turn around, walk back, and sit down (seconds). Longer completion times indicate poorer functional mobility and balance. |
Baseline
|
|
Lower Extremity Functional Scale (LEFS)
Délai: Baseline
|
Self-reported lower extremity function assessed using a 20-item questionnaire with a total score ranging from 0 to 80. Higher scores indicate better lower extremity function and less disability. |
Baseline
|
|
Visual Analog Scale (VAS)
Délai: Baseline
|
Pain intensity assessed using a 100-mm visual analog scale ranging from 0 (no pain) to 100 (worst imaginable pain). Higher scores indicate greater pain intensity. |
Baseline
|
Collaborateurs et enquêteurs
Les enquêteurs
- Chercheur principal: Nurdan Paker, Prof, Istanbul Physical Medicine Rehabilitation Training and Research Hospital
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- Istftreah15
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .